(0.09%) 5 211.00 points
(0.05%) 39 016 points
(-0.06%) 18 184 points
(-0.90%) $77.77
(-1.28%) $2.17
(-0.36%) $2 322.80
(0.08%) $27.64
(2.00%) $984.20
(-0.05%) $0.928
(0.30%) $10.86
(0.06%) $0.796
(-0.38%) $91.00
-7.87% $ 0.130
Live Chart Being Loaded With Signals
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 5.15M |
Średni wolumen | 2.06M |
Kapitalizacja rynkowa | 18.29M |
EPS | $0 ( 2024-03-25 ) |
Następna data zysków | ( $-0.100 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.290 |
ATR14 | $0.00200 (1.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-01 | Ray Sumita | Buy | 425 000 | Employee Stock option (right to buy) |
2023-11-03 | Paula Molina Rene | Buy | 0 | |
2023-10-02 | Powchik Peter | Buy | 159 744 | Stock option (right to buy) |
2023-10-01 | Ray Sumita | Buy | 0 | |
2023-09-06 | Prime Movers Lab Fund I Lp | Sell | 5 308 | Class A Common Stock |
INSIDER POWER |
---|
55.11 |
Last 91 transactions |
Buy: 6 350 518 | Sell: 2 608 586 |
Wolumen Korelacja
Vaxxinity, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
DUNE | 0.92 |
CIIG | 0.918 |
ONEM | 0.906 |
LGVC | 0.902 |
POAI | 0.902 |
YVR | 0.901 |
MEUSW | 0.894 |
BBCP | 0.886 |
MRNS | 0.876 |
VYGR | 0.876 |
10 Najbardziej negatywne korelacje | |
---|---|
NYMX | -0.905 |
RANI | -0.903 |
CHCI | -0.903 |
GAIA | -0.898 |
THCP | -0.886 |
GRIN | -0.879 |
ABIO | -0.879 |
CSTE | -0.873 |
CATB | -0.869 |
CADL | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vaxxinity, Inc. Korelacja - Waluta/Towar
Vaxxinity, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.23M (0.00 %) |
EPS: | $-0.450 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.23M (0.00 %) |
EPS: | $-0.450 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.68M (0.00 %) |
EPS: | $-0.600 |
FY | 2021 |
Przychody: | $66 000.00 |
Zysk brutto: | $-1.87M (-2 834.85 %) |
EPS: | $-1.100 |
Financial Reports:
No articles found.
Vaxxinity, Inc.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej